CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Income Statement
NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 26.03M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 46.48M | 71.93M | 784.12M | 628.13M | 190.99M | |||
| Research and Development | 28.46M | 53.00M | 652.21M | 518.02M | 150.93M | |||
| Selling, General, and Administrative Expenses | 18.03M | 16.05M | 139.44M | 122.45M | 47.72M | |||
| Operating Income | -20.45M | -71.93M | -784.12M | -628.13M | -190.99M | |||
| Interest Income/Expense | 4.45M | 8.10M | 21.91M | -2.73M | -8.95M | |||
| Other Income/Expense | 2.59M | 1.85M | 0.00 | -674.27M | -579.29M | |||
| Non Recurring Items | -2.00M | 0.00 | -32.81M | N/A | N/A | |||
| Income Before Taxes | -15.40M | -61.99M | -795.02M | -1.31B | -779.23M | |||
| Income Tax | 223.00K | 120.00K | 2.04M | 1.70M | 0.00 | |||
| Net Income | -15.63M | -62.11M | -797.06M | -1.31B | -779.23M | |||
| EBITDA | -19.79M | -71.20M | -777.18M | -624.05M | -189.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.28 | -1.13 | -13.86 | -22.71 | -13.95 | |||
| Statistics | ||||||||
| Profit Margin | -60.03% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -78.56% | N/A | N/A | N/A | N/A | |||
All data in USD